Products & Services · Revenues:

Talzenna — Revenues:

Pfizer Talzenna — Revenues: increased by 2.0% to $50.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.0%, from $40.00M to $50.00M. Over 3 years (FY 2022 to FY 2025), Talzenna — Revenues: shows an upward trend with a 55.9% CAGR.

Analysis

StatementSegment
First reportedQ1 2022
Last reportedQ1 2026May 5, 2026
Rolls up toTotal Revenue
Metric ID: pfe_segment_talzenna_revenues

Historical Data

17 periods
 Q1 '22Q2 '22Q3 '22Q4 '22Q1 '23Q2 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Value$12.00M$12.00M$12.00M$12.00M$10.00M$12.00M$20.00M$22.00M$23.00M$32.00M$36.00M$26.00M$40.00M$46.00M$47.00M$49.00M$50.00M
QoQ Change—+0.0%+0.0%+0.0%-16.7%+20.0%+66.7%+10.0%+4.5%+39.1%+12.5%-27.8%+53.8%+15.0%+2.2%+4.3%+2.0%
YoY Change————-16.7%+0.0%+66.7%+83.3%+130.0%+166.7%+80.0%+18.2%+73.9%+43.8%+30.6%+88.5%+25.0%
Range$10.00M – $50.00M
CAGR+42.9%
Avg YoY Growth+60.8%
Median YoY Growth+66.7%
Current Streak5 quarters growth

Frequently Asked Questions

What is Pfizer's talzenna — revenues:?
Pfizer (PFE) reported talzenna — revenues: of $50.00M in Q1 2026.
How has Pfizer's talzenna — revenues: changed year-over-year?
Pfizer's talzenna — revenues: increased by 25.0% year-over-year, from $40.00M to $50.00M.
What is the long-term trend for Pfizer's talzenna — revenues:?
Over 3 years (2022 to 2025), Pfizer's talzenna — revenues: has grown at a 55.9% compound annual growth rate (CAGR), from $48.00M to $182.00M.